Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients

This study has been completed.
Eli Lilly and Company
Information provided by (Responsible Party):
Harold L. Lazar MD, American Heart Association Identifier:
First received: December 18, 2007
Last updated: June 22, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2015
  Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)